Natera, Inc. (NASDAQ: NTRA) has announced its acquisition of certain reproductive health assets from Invitae (NYSE: NVTA), a leading medical genetics company. The acquisition includes an upfront payment of $10 million to Invitae, along with potential milestone payments totaling $42.5 million, comprising cash and litigation-related credits. As part of the agreement, Invitae will transition its non-invasive prenatal screening and carrier screening customers to Natera.
Steve Chapman, the chief executive officer of Natera, expressed the company's commitment to providing excellent service and its anticipation of supporting additional patients and providers as a result of the acquisition.
Natera, a global leader in cell-free DNA testing, operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. The company's tests are validated by more than 180 peer-reviewed publications, demonstrating high accuracy.
Following the announcement, Natera's shares have experienced a 2.5% increase, reaching a trading price of $68.28.
The company's full 8-K submission is available here.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Revenue (k) | $257,654 | $302,328 | $391,005 | $625,486 | $820,222 | $988,718 |
| Revenue Growth | n/a | 17.34% | 29.33% | 59.97% | 31.13% | 20.54% |
| Net Margins | -50% | -41% | -59% | -75% | -67% | -51% |
| Net Income (k) | -$128,154 | -$124,827 | -$229,743 | -$471,716 | -$547,799 | -$499,343 |
| Net Interest Expense (k) | -$2,729 | $4,152 | $7,562 | $5,381 | $3,538 | $16,882 |
| Depreciation & Amort. (k) | $1,300 | $7,730 | $8,613 | $11,300 | $16,700 | $20,600 |
| Earnings Per Share | -$2.22 | -$1.79 | -$2.84 | -$5.21 | -$5.57 | -$4.34 |
| EPS Growth | n/a | 19.37% | -58.66% | -83.45% | -6.91% | 22.08% |
| Diluted Shares (k) | 57,848 | 69,555 | 81,011 | 90,558 | 98,408 | 115,171 |
| Capital Expenditures | $12 | $4,968 | $19,604 | $41,030 | $47,697 | $41,494 |
| Current Ratio | 2.11 | 2.91 | 4.33 | 4.99 | 3.9 | 4.37 |
